No Deal Brexit Could Mean 'Considerable Obstacles' For German OTC Exports
Executive Summary
The dangers of a hard Brexit, a welcome delay to the EU Medical Devices Regulation and the impact of the coronavirus on the German OTC market all feature in this exclusive HBW Insight catch up with Germany's self-medication industry association, the BAH.
You may also be interested in...
How To Get A ‘Great Britain’ Drug Approval In 2021
So much will change on the regulatory front next year that the UK drug regulator, the MHRA, has had to issue dozens of new guidance documents to help pharma and biotech firms navigate the new requirements and assessment routes. A key consideration is how the UK will handle centralized EU applications that are still pending on 31 December.
Haleon Smashes Toothpaste Tube Recycling Target
Haleon has rolled out 1.2bn recycle-ready tubes across the world, an achievement that the firm said is a “milestone” on its “journey towards realizing a circular economy for its product packaging.” Haleon is also introducing a more sustainable manufacturing process for several variants of its Sensodyne toothpaste brand, starting in the UK.
Over The Counter 18 Mar 2024: How AI Is Revolutionizing Personalized Wellness, With Bioniq’s Marni Allen
In this episode, HBW Insight dives into personalized wellness with Marni Allen, chief marketing officer at tailored supplements manufacturer Bioniq. Named as one of EY UK's 50 Women to Watch in 2022, Allen has over 20 years’ experience in consumer healthcare, and is now working with Bioniq to create the next generation of bespoke wellness products for consumers across the world. As well as its top tier at-home blood test-based service, Bioniq also offers an affordable questionnaire-based option, which leverages the power of AI to analyse users’ nutritional needs and provide unique supplement formulations in the post. Although personalized wellness is still somewhat niche, Allen suggests that AI-based models like Bioniq offer an attractive option for traditional consumer health companies looking to get into this fast-growing market.